Related Experiment Video
Updated: Aug 30, 2026
Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
Updates in small cell lung cancer treatment
1WalkerS@tuhs.temple.edu
Abstract:
Lung cancer is divided into two major histologic types: small cell lung cancer (SCLC) and non-small cell lung cancer. SCLC is rapidly progressive and, without treatment, may be fatal in as few as 12 weeks. Fortunately, SCLC is a very chemotherapy- and radiation-sensitive disease, and a variety of chemotherapy agents have demonstrated activity against it. This article provides an overview of SCLC, including current treatment strategies for limited, extensive, and recurrent disease. By understanding the various traditional and emerging treatment modalities, nurses can better assess their patients and help to reduce potential SCLC treatment complications.
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against specific...
02:49Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...